Patent details

Basic Information

Publication number:

EP2903600

PCT Application Number:

EP2013070590

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137769915

PCT Publication Number:

WO2014053571

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

VIRUS-CONTAINING FORMULATION AND USE THEREOF

French Title of Invention:

FORMULATION CONTENANT UN VIRUS ET UTILISATION ASSOCIÉE

German Title of Invention:

VIRENHALTIGE FORMULIERUNG UND VERWENDUNG DAVON

SPC Number:

Dates

Filing date:

02/10/2013

Grant date:

31/08/2022

EP Publication Date:

12/08/2015

PCT Publication Date:

10/04/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

31/08/2022

EP B1 Publication Date:

31/08/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/10/2022

Expiration date:

02/10/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/08/2022

 

 

Name:

TRANSGENE

Address:

Parc d'Innovation Boulevard Gonthier d'Andernach, 67400 Illkirch Graffenstaden, France (FR)

Inventor

1

Name:

SENE, Claude

Address:

France (FR)

2

Name:

CHASLE, Mélina

Address:

France (FR)

Priority

Priority Number:

12306198

Priority Date:

02/10/2012

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/19; A61K 47/18; A61K 47/20; A61K 47/32; A61P 1/16; A61P 31/12; A61P 35/00; A61P 37/02; A61K 39/00;

Publication

European Patent Bulletin

Issue number:

202235

Publication date:

31/08/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages